 |
 |
SENIOR MANAGEMENT
View full biographies
|
Safi R. Bahcall, Ph.D.
President and Chief Executive Officer
|
|
Keizo Koya, Ph.D.
Senior Vice President, Drug Development
|
|
Amar Singh
Senior Vice President and Chief Business Officer
|
|
Vojo Vukovic, M.D., Ph.D.
Senior Vice President, Chief Medical Officer
|
|
Eric Rowinsky, M.D.
Scientific Advisor
|
|
Suresh R. Babu, Ph.D.
Vice President, Drug Product Development
|
|
Keith S. Ehrlich, C.P.A
Vice President, Finance and Administration Chief Financial Officer
|
|
Iman El-Hariry, M.D., Ph.D.
Vice President, Clinical Research
|
|
Rob Kloppenburg
Vice President, Investor Relations and Corporate Communications
|
|
Arthur J. McMahon
Vice President, Human Resources
|
|
Wendy E. Rieder, Esq.
Vice President, Intellectual Property and Legal Affairs General Counsel
|
|
Andrew J. Sonderfan, Ph.D., DABT
Vice President, Drug Disposition and Preclinical Safety
|
|
Ilker Yalcin, Ph.D., M.B.A.
Vice President, Biostatistics & Data Management
|
|
David Noskowitz
Senior Director, Regulatory Affairs
|
[Top of page]
BOARD OF DIRECTORS
View full biographies
|
Keith R. Gollust
Director and Chairman
|
|
Safi R. Bahcall, Ph.D.
President and Chief Executive Officer
|
|
Lan Bo Chen, Ph.D.
Director, Scientific Founder
|
|
Bruce Kovner
Director
|
|
Donald W. Kufe, M.D.
Director
|
|
William S. Reardon, C.P.A.
Director
|
|
Robert N. Wilson
Director
|
[Top of page]
|
|